FDA Inspection
Englewood Lab Korea Co., Ltd.Englewood Lab Korea Co., Ltd. – FDA Inspection, Jul 12, 2019
Record Details
This FDA Inspection record concerns Englewood Lab Korea Co., Ltd., with an inspection on July 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c2437e60-b6f3-41ad-bd18-957bb0170688
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096066
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
13- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.192Investigations of discrepancies, failures
Showing 10 of 13 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Englewood Lab Korea Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 25, 2024 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
Other documents for Englewood Lab Korea Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.